In the announcement, FDA Commissioner Mackary said, “Bayesian methodologies help address two of the biggest problems of drug development: high costs and long timelines. Providing clarity around modern ...
The FDA's move to incorporate Bayesian statistical methods into clinical trials of drugs and biologics garnered special treatment in JAMA this week. JAMA published three perspectives -- two welcoming ...
The ability to make adaptive decisions in uncertain environments is a fundamental characteristic of biological intelligence. Historically, computational ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results